Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest lung cancer Stories

2014-02-05 12:28:35

New Members Contribute Expertise and Vision to LUNGevity's Research Program WASHINGTON, Feb. 5, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, one of the nation's premier lung cancer research foundations, announces two key additions to its Scientific Advisory Board: Dr. Julie Brahmer of Johns Hopkins and Dr. John Heymach of MD Anderson Cancer Center. The Scientific Advisory Board is an integral part of the foundation, guiding LUNGevity's funding of research into early detection...

2014-02-04 16:29:22

MADISON, Wis., Feb. 4, 2014 /PRNewswire-USNewswire/ -- Changing its name - but not its focus - the National Lung Cancer Partnership is now Free to Breathe, a name that conveys the organization's passion, dedication and vision to double lung cancer survival by 2022, empower advocates and help every person affected by the disease. "Free to Breathe resonates deeply with people whose lives have been affected by lung cancer, and it embodies who we are and what we do," said Joan H....

WHO Report Warns Of Impending Global Cancer Disaster
2014-02-04 08:31:27

[ Watch the Video: World Cancer Day 2014 ] Lawrence LeBlond for redOrbit.com - Your Universe Online Coinciding with World Cancer Day, the World Health Organization’s (WHO) International Agency for Research on Cancer (IACR) released the World Cancer Report 2014, which highlights the need for health professionals around the world to strengthen prevention efforts on a disease that is quickly becoming a global health disaster. The report maintains that the “global battle against...

2014-01-29 23:30:38

During National Radon Action Month, Grinnell Mutual encourages Midwesterners to test their homes and business for the second leading cause of lung cancer, radon. Grinnell, IA (PRWEB) January 29, 2014 During National Radon Action Month, Grinnell Mutual encourages Midwesterners to test their homes and business for the second leading cause of lung cancer, radon. According to the Environmental Protection Agency (EPA), radon is responsible for more than 20,000 lung cancer deaths per year....

2014-01-29 13:16:56

A University of Colorado Cancer Center study published today in the International Journal of Radiation Oncology Biology and Physics shows that patients taking crizotinib for ALK+ non-small cell lung cancer may safely and durably use up to three courses of targeted radiation therapy to eradicate pockets of drug-resistant disease. Eliminating these pockets of resistant disease allows patients to continue treating the overall condition with crizotinib, leading to improved 2-year survival rates...

2014-01-29 08:27:03

First Joint Project Involves a $20 Million Dream Team Grant for Lung Cancer Research To Be Awarded in 2015 LOS ANGELES, Jan. 29, 2014 /PRNewswire/ -- The American Cancer Society, the largest voluntary health organization in the world dedicated to eliminating cancer, and Stand Up To Cancer (SU2C), the charitable initiative supporting groundbreaking research aimed at getting new treatments to patients in an accelerated time frame, announced today an historic collaboration in the...

2014-01-28 23:29:51

North Broward Radiologists, a Florida-based radiology group, now offers lung cancer screenings for patients in high-risk populations. Fort Lauderdale, Florida (PRWEB) January 28, 2014 New legislation under the Affordable Health Care Act guarantees full insurance coverage of annual lung cancer screenings for high-risk patients. North Broward Radiologists (NBR) is excited to announce current availability for high quality, effective lung cancer screening for these patients. Patients included...

2014-01-24 08:24:33

HAIFA, Israel, Jan. 24, 2014 /PRNewswire/ -- Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma. NovoTTF Therapy is an anti-mitotic treatment delivered continuously with a wearable, home-use medical device. "The EF-20 study builds on extensive preclinical research demonstrating the...

2014-01-17 20:21:56

MELBOURNE, Australia, Jan. 17, 2014 /PRNewswire/ -- -- Study shows ABRAXANE plus gemcitabine combination therapy further extends overall survival benefit -- First Phase III trial in metastatic pancreatic cancer to report three year survival rates[1] -- New standard of care for patients with metastatic pancreatic cancer A leading breast cancer drug, ABRAXANE(®)( )(nanoparticle albumin-bound paclitaxel), has been shown to extend overall survival (OS) for...

2014-01-17 00:21:50

WASHINGTON, Jan. 17, 2014 /PRNewswire-USNewswire/ -- The following is Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids: (Logo: http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO) Fifty years after the first Surgeon General's report on smoking and health, the new Surgeon General's report released today shows that cigarette smoking is even more hazardous than previously thought. This report documents that smoking causes even more diseases, kills even more people and...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »